NCT06640062

Brief Summary

The aim of this work was to compare the effect of using oblique subcostal transversus abdominis plane (OSTAP) block and erector spinae plane (ESP) block as a part of multi-modal analgesia technique in patients undergoing laparoscopic cholecystectomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 10, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

1.7 years

First QC Date

October 10, 2024

Last Update Submit

October 10, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Degree of pain intensity

    The degree of pain intensity was assessed using the Visual Analogue Scale (VAS). Each patient was instructed about postoperative pain assessment with the VAS. VAS(0 represents "no pain" while 10 represents "the worst pain imaginable"). It was assessed at 30 minutes, 2, 4, 6, 8, 12, 16, 20, and 24 hours postoperatively.

    24 hours postoperatively

Secondary Outcomes (5)

  • Time to first rescue analgesia

    24 hours postoperatively

  • Total amount of morphine consumption

    24 hours postoperatively

  • Morphine-related side effects

    24 hours postoperatively

  • Local anesthetics-related side effects

    24 hours postoperatively

  • Incidence of adverse effects of the block technique

    24 hours postoperatively

Study Arms (2)

Erector spinae plane block group

ACTIVE COMPARATOR

Patients received ultrasound-guided erector spinae plane block.

Other: Erector spinae plane block

Oblique subcostal transversus abdominis plane block group

EXPERIMENTAL

Patients received ultrasound-guided oblique subcostal transversus abdominis plane block.

Other: Oblique subcostal transversus abdominis plane block

Interventions

Patients received ultrasound-guided erector spinae plane block.

Erector spinae plane block group

Patients received ultrasound-guided oblique subcostal transversus abdominis plane block.

Oblique subcostal transversus abdominis plane block group

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age from 20 to 60 years.
  • Both gender.
  • American Society of Anesthesiologists (ASA) grade I and II physical status.
  • Body mass index (BMI): ≥ 20 kg/m2 and ≤ 35 kg/m2.
  • Underwent laparoscopic cholecystectomy.

You may not qualify if:

  • Patient refusal.
  • Known sensitivity or contraindication to drugs used in the study (local anesthetics, opioids).
  • History of psychological disorders and/or chronic pain syndrome.
  • Contraindication to regional anesthesia, e.g., local sepsis, pre-existing peripheral neuropathies, and coagulopathy.
  • Severe respiratory disorders such as (severe obstructive pulmonary disease, forced expiratory volume (FEV1), forced vital capacity (FVC) \<50% or severe restrictive pulmonary disease, and adult respiratory distress syndrome).
  • Severe cardiac disorders such as (heart failure).
  • Advanced liver disease (elevated liver enzymes more than 3 folds of normal range).
  • Advanced kidney disease (Decreased creatinine clearance \<40 ml/min).
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Helwan University

Helwan, Cairo Governorate, 11795, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Helwan University, Egypt.

Study Record Dates

First Submitted

October 10, 2024

First Posted

October 15, 2024

Study Start

January 1, 2023

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

October 15, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author.

Locations